These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


594 related items for PubMed ID: 6193338

  • 1. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M, Bartsch W, Thomsen M, Voigt KD.
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [Abstract] [Full Text] [Related]

  • 2. [Androgen receptor and 5 alpha-reductase activity in the epithelium and the stroma of human benign prostatic hyperplasia].
    Oishi K, Okada K, Yoshida O, Romijn JC, Bolt de Vries J, Schröder FH.
    Hinyokika Kiyo; 1985 May; 31(5):785-90. PubMed ID: 2413745
    [Abstract] [Full Text] [Related]

  • 3. [Androgen and estrogen metabolism in human benign prostatic hyperplasia (BPH)].
    Krieg M, Weisser H, Tunn S.
    Verh Dtsch Ges Pathol; 1993 May; 77():19-24. PubMed ID: 7511279
    [Abstract] [Full Text] [Related]

  • 4. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate.
    Krieg M, Nass R, Tunn S.
    J Clin Endocrinol Metab; 1993 Aug; 77(2):375-81. PubMed ID: 7688377
    [Abstract] [Full Text] [Related]

  • 5. [Activity of 5 alpha-reductase in human hyperplastic prostates].
    Lin Y.
    Zhonghua Yi Xue Za Zhi; 1991 May; 71(5):263-5, 20. PubMed ID: 1713809
    [Abstract] [Full Text] [Related]

  • 6. Effect of aging on kinetic parameters of 3 alpha(beta)-hydroxysteroid oxidoreductases in epithelium and stroma of human normal and hyperplastic prostate.
    Tunn S, Haumann R, Hey J, Flüchter SH, Krieg M.
    J Clin Endocrinol Metab; 1990 Sep; 71(3):732-9. PubMed ID: 1697599
    [Abstract] [Full Text] [Related]

  • 7. Effect of aging on kinetic parameters of 5 alpha-reductase in epithelium and stroma of normal and hyperplastic human prostate.
    Tunn S, Hochstrate H, Grunwald I, Flüchter SH, Krieg M.
    J Clin Endocrinol Metab; 1988 Nov; 67(5):979-85. PubMed ID: 2460487
    [Abstract] [Full Text] [Related]

  • 8. Endogenous androgen levels in epithelium and stroma of human benign prostatic hyperplasia and normal prostate.
    Bartsch W, Krieg M, Becker H, Mohrmann J, Voigt KD.
    Acta Endocrinol (Copenh); 1982 Aug; 100(4):634-40. PubMed ID: 6181638
    [Abstract] [Full Text] [Related]

  • 9. Clinical and experimental studies of benign prostatic hyperplasia.
    Coffey DS, Walsh PC.
    Urol Clin North Am; 1990 Aug; 17(3):461-75. PubMed ID: 1695775
    [Abstract] [Full Text] [Related]

  • 10. Androgens and estrogens in the plasma and prostatic tissue of normal dogs and dogs with benign prostatic hypertrophy.
    Lloyd JW, Thomas JA, Mawhinney MG.
    Invest Urol; 1975 Nov; 13(3):220-22. PubMed ID: 53217
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
    Mendoza P, Sánchez C, Contreras HR, Vergara J, Acevedo C, Cabezas J, Huidobro C, Noé G, Castellón EA.
    Int J Androl; 2009 Dec; 32(6):607-15. PubMed ID: 18637152
    [Abstract] [Full Text] [Related]

  • 14. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
    Monti S, Di Silverio F, Iraci R, Martini C, Lanzara S, Falasca P, Poggi M, Stigliano A, Sciarra F, Toscano V.
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
    [Abstract] [Full Text] [Related]

  • 15. The effect of estrogen supplementation on cell proliferation and expression of c-kit positive cells in the rat prostate.
    Kusljic S, Exintaris B.
    Prostate; 2010 Oct 01; 70(14):1555-62. PubMed ID: 20687229
    [Abstract] [Full Text] [Related]

  • 16. Role of stroma in carcinogenesis of the prostate.
    Cunha GR, Hayward SW, Wang YZ.
    Differentiation; 2002 Dec 01; 70(9-10):473-85. PubMed ID: 12492490
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
    Boudon C, Lobaccaro JM, Lumbroso S, Lechevallier E, Mottet N, Gibelin B, Sultan C.
    Cell Mol Biol (Noisy-le-grand); 1995 Dec 01; 41(8):1007-15. PubMed ID: 8747081
    [Abstract] [Full Text] [Related]

  • 19. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK, Ross M, Tate R, Chisholm GD.
    Clin Endocrinol (Oxf); 1997 Feb 01; 46(2):137-44. PubMed ID: 9135694
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.